» Articles » PMID: 35364097

The Epidemiology of Biliary Atresia: Exploring the Role of Developmental Factors on Birth Prevalence

Abstract

Objective: To identify key epidemiologic factors relevant to fetal development that are associated with biliary atresia.

Study Design: This population-based registry study examined infants born in Texas between 1999 and 2014. Epidemiologic data relevant to fetal development were compared between cases of biliary atresia identified in the Texas Birth Defects Registry (n = 305) vs all live births (n = 4 689 920), and Poisson regression was used to calculate prevalence ratios (PRs) and 95% CIs.

Results: The prevalence of biliary atresia over the study period was 0.65 per 10 000 live births. Biliary atresia was positively associated with female sex (adjusted PR, 1.68; 95% CI, 1.33-2.12), delivery before 32-37 weeks of gestation (adjusted PR, 1.64; 95% CI, 1.18-2.29), delivery before 32 weeks of gestation (adjusted PR, 3.85; 95% CI, 2.38-6.22), and non-Hispanic Black vs non-Hispanic White maternal race/ethnicity (adjusted PR, 1.54, 95% CI, 1.06-2.24), while biliary atresia was inversely associated with season of conception in the fall relative to spring (adjusted PR, 0.62; 95% CI, 0.45-0.86). In addition, biliary atresia was associated with maternal diabetes (adjusted PR, 2.34; 95% CI, 1.57-3.48), with a stronger association with pregestational diabetes compared with gestational diabetes. In subgroup analyses, these associations were present in isolated biliary atresia cases that do not have any additional birth defects.

Conclusions: Biliary atresia is associated with multiple factors related to fetal development, including pregestational maternal diabetes, female sex, and preterm birth. These associations also were observed in isolated cases of biliary atresia without other malformations or laterality defects. Our results are consistent with early life events influencing the pathogenesis of biliary atresia, and support further studies investigating in utero events to better understand etiology and time of onset.

Citing Articles

Development of an artificial intelligence-based multimodal diagnostic system for early detection of biliary atresia.

Ma Y, Yang Y, Du Y, Jin L, Liang B, Zhang Y BMC Med. 2025; 23(1):127.

PMID: 40016769 PMC: 11866655. DOI: 10.1186/s12916-025-03962-x.


Experience of post-traumatic growth among parents of children with biliary atresia undergoing living-related liver transplantation: a descriptive phenomenological study.

Li Z, Lu F, Dong L, Zheng L, Wu J, Wu S Eur J Psychotraumatol. 2025; 16(1):2447184.

PMID: 39780764 PMC: 11721874. DOI: 10.1080/20008066.2024.2447184.


Microcystin-RR is a biliary toxin selective for neonatal extrahepatic cholangiocytes.

Gupta K, Chen D, Wells R JHEP Rep. 2024; 7(1):101218.

PMID: 39687604 PMC: 11648759. DOI: 10.1016/j.jhepr.2024.101218.


Population-based screening strategies for biliary atresia in the newborn: A systematic review and meta-analysis.

Hari Gopal S, Zebda R, Mohan A, Borovsky K, Takwoingi Y, Scandrett K PLoS One. 2024; 19(8):e0307837.

PMID: 39197055 PMC: 11357077. DOI: 10.1371/journal.pone.0307837.


Heritable Chronic Cholestatic Liver Diseases: A Review.

Tidwell J, Wu G J Clin Transl Hepatol. 2024; 12(8):726-738.

PMID: 39130622 PMC: 11310751. DOI: 10.14218/JCTH.2024.00119.


References
1.
Moyer V . Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014; 160(6):414-20. DOI: 10.7326/M13-2905. View

2.
Suarez L, Felkner M, Brender J, Canfield M, Zhu H, Hendricks K . Neural tube defects on the Texas-Mexico border: what we've learned in the 20 years since the Brownsville cluster. Birth Defects Res A Clin Mol Teratol. 2012; 94(11):882-92. DOI: 10.1002/bdra.23070. View

3.
Muraji T, Hosaka N, Irie N, Yoshida M, Imai Y, Tanaka K . Maternal microchimerism in underlying pathogenesis of biliary atresia: quantification and phenotypes of maternal cells in the liver. Pediatrics. 2008; 121(3):517-21. DOI: 10.1542/peds.2007-0568. View

4.
Wada H, Muraji T, Yokoi A, Okamoto T, Sato S, Takamizawa S . Insignificant seasonal and geographical variation in incidence of biliary atresia in Japan: a regional survey of over 20 years. J Pediatr Surg. 2007; 42(12):2090-2. DOI: 10.1016/j.jpedsurg.2007.08.035. View

5.
Mysore K, Shneider B, Harpavat S . Biliary Atresia as a Disease Starting In Utero: Implications for Treatment, Diagnosis, and Pathogenesis. J Pediatr Gastroenterol Nutr. 2019; 69(4):396-403. PMC: 6942669. DOI: 10.1097/MPG.0000000000002450. View